SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001553350-22-000467
Filing Date
2022-05-16
Accepted
2022-05-16 16:44:00
Documents
15
Period of Report
2022-05-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT nhwk_8k.htm   iXBRL 8-K 27248
2 AUDITED FINANCIALS nhwk_ex99z1.htm EX-99.1 14280
3 GRAPHIC image_001.jpg GRAPHIC 6492
  Complete submission text file 0001553350-22-000467.txt   270882

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nhwk-20220516.xsd EX-101.SCH 3471
5 XBRL DEFINITION FILE nhwk-20220516_def.xml EX-101.DEF 26569
6 XBRL LABEL FILE nhwk-20220516_lab.xml EX-101.LAB 36527
7 XBRL PRESENTATION FILE nhwk-20220516_pre.xml EX-101.PRE 25193
9 EXTRACTED XBRL INSTANCE DOCUMENT nhwk_8k_htm.xml XML 5277
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
NightHawk Biosciences, Inc. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 22930198
SIC: 2834 Pharmaceutical Preparations